Role of PDGF in fibrotic diseases and systemic sclerosis
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
PDGF functions as a primary mitogen and chemoattractant for cells of mesenchymal origin. Members of the PDGF family play an important role during embryonic development and contribute to the maintenance of connective tissue in adults. Deregulation of PDGF signalling has been linked to atherosclerosis, pulmonary hypertension and organ fibrosis. Elevated expression of PDGF and its receptors has been found in scleroderma skin and lung tissues. There is evidence for a TGF-beta and IL-1alpha-dependent autocrine PDGF-A/PDGFRalpha signalling loop in scleroderma skin and lung fibroblasts, suggesting that a cross-talk between TGF-beta and PDGF pathways may regulate chronic fibrosis in scleroderma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been shown that persistent inflammation results in up-regulation of various proinflammatory cytokines and chemokines, which further induce the expression of growth factors (e.g., PDGF, TGF-β1, activin), stimulating fibroblast proliferation, their differentiation into myofibroblasts, and production of ECM in a variety of fibrotic diseases, including hypertrophic scars and keloids [259–261].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [260]
In the citing paper
“In CIDs of different etiology, serum androgens are very low [94-96], but estrogen levels remain relatively normal as a consequence of increased conversion of androgens into estrogens in inflamed tissue [97].”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [97]
Citations
Cites
Reversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis
Svegliati Baroni, S., Santillo, M., Bevilacqua, F., Luchetti, M., Spadoni, T., Mancini, M., Fraticelli, P., Sambo, P., Funaro, A., Kazlauskas, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052955 · Cited by 585
PDGF and cardiovascular disease
Raines, E. W. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.004 · Cited by 484
PDGF signaling in cells and mice
Tallquist, M., & Kazlauskas, A. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.003 · Cited by 392
Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
Alvarez, R. H., Kantarjian, H. M., & Cortes, J. E. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1241 · Cited by 334
A New Look at Platelet-Derived Growth Factor in Renal Disease
Floege, J. D., Eitner, F., & Alpers, C. E. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050532 · Cited by 302
Reigstad, L. J., Varhaug, J. E., & Lillehaug, J. R. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04989.x · Cited by 236
Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A
Kawaguchi, Y., Hara, M., & Wright, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4304 · Cited by 187
Yamakage, A., Kikuchi, K., Smith, E. A., LeRoy, E. C., & Trojanowska, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1227 · Cited by 184
Self-citation
Research works printed but not linked: 1
- Ludwicka, 1995, The Journal of rheumatology, 22, 1876
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Allanore, Y., Simms, R., Distler, O., Trojanowska, M., Pope, J., Denton, C. P., & Varga, J. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.2 · Cited by 876
Self-citationPathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
“org Other potential mediators of this transformative process include PDGF (286), VEGF (287), insulin-derived growth factor (288), CTGF (289), ET-1 (290), and miRNAs (291, 292).”
BackgroundInfluentialMolecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
“[38,44-54]”
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
Ma, W.-T., Gao, F., Gu, K., & Chen, D.-K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01140 · Cited by 361
Metadata
- Authors
- Trojanowska, M.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Trojanowska, M.
- ORCID
- Trojanowska, M.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 47
- Issue
- Supplement 5
- Pages
- v2-v4
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2131369107
- Cited by
- 213
- References
- 15
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 16 · 2021: 12 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 11 · 2016: 19 · 2015: 20 · 2014: 11 · 2013: 12 · 2012: 23
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- platelet-derived growth factor, systemic sclerosis, fibrosis, PDGF receptor, PDGF-A, PDGFRA, TGF-beta signaling, IL-1α, autocrine signaling, fibroblasts, connective tissue, atherosclerosis, pulmonary hypertension, embryonic development
- MeSH terms
- Animals, Female, Fibroblasts, Humans, Lung, Platelet-Derived Growth Factor, Pregnancy, Scleroderma, Systemic, Skin, Signal Transduction, Transforming Growth Factor beta, Receptors, Platelet-Derived Growth Factor, Lung Diseases, Interstitial, Receptors, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of PDGF in fibrotic diseases and systemic sclerosis. https://app.cochat.ai/papers/10.1093/rheumatology/ken265
- The paper
- Trojanowska, M. (2008). Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology. https://doi.org/10.1093/rheumatology/ken265
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.